Stock 688578 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Allist Pharmaceuticals Co., Ltd.

Equities

688578

CNE100005XJ7

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
61.9 CNY -2.60% Intraday chart for Shanghai Allist Pharmaceuticals Co., Ltd. +6.50% +48.58%
05-09 Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib MT
04-25 Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Shanghai Allist Pharmaceuticals Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

75fc5d651ef47246132e.c3Mq0yndXBc8YJWD01hEHO8RSjiTMhtftvj52dUOUJU.IyV74RipElh_UfvrjC1zZL10JnL7WCku3LeTlaNEGLgGIEuQQ5AORFkYxA~1ae3829aa275a662a08251a475c90a4d

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
61.9
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Ratings for Shanghai Allist Pharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 688578 Stock
  4. Consensus Shanghai Allist Pharmaceuticals Co., Ltd.